A Study of DB-1310 in Advanced/Metastatic Solid Tumors

NCT05785741 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: DB-1310
DRUG: Trastuzumab
DRUG: Osimertinib
DRUG: capecitabine

Sponsor

DualityBio Inc.